NYSE

Quick Read A hotter-than-expected July CPI print could spark heavy selling, as markets closed lower Tuesday except the…

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are far and away the heavyweights in the global…

The human appetite has more than one off switch, and drugmakers like Eli Lilly (NYSE: LLY) and Novo…

The S&P 500 index (SNPINDEX: ^GSPC) has a tiny little 1% yield today. Novo Nordisk (NYSE: NVO) is…

Key Points Pfizer has regrouped in the GLP-1 space and is now working on a long-acting drug option.…

Demand for GLP-1 medicines is booming, as these drugs have proven highly effective at treating diabetes, obesity, and…

Pharmaceutical giants Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are still the two titans of the…

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT…

Shares of Eli Lilly (NYSE: LLY) have risen 400% over the past five years. Novo Nordisk (NYSE: NVO)…

You probably already know that pharmaceutical powerhouses Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) dominate the…

Key Points CVS Health has a far more diversified business than Novo Nordisk. Both approaches have perks and…

Key Points Hims & Hers’ stock is up after ending its lawsuit with Novo Nordisk. The deal shows…

Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More